GlobalData: U.S. should provide citizens with lifesaving tools to reduce COVID-19 second wave

NewsGuard 100/100 Score

Following the news that the US Senate is considering the ‘Opening Up America Again’ act;

James Spencer, Data Scientist at GlobalData, a leading data and analytics company, offers his view on the country reopening plan:

Many countries have started to feel the pinch to their stalled economies and some have started to open their economies again. However, the US will need much more in the way of healthcare infrastructure to make this a reality.

Many countries are turning an eye towards regaining their pre-COVID freedom but this has not always ended well. In the case of Hokkaido underwent stringent lockdown and had one of the world’s fewest new cases per capita. However, when it opened the economy back up under pressure from the business sector, a second wave of COVID-19 broke out - far exceeding the first wave in size and severity. If the US is to avoid Hokkaido’s mistakes, it must take several steps in the healthcare field such as equipping the general population with masks, gloves and other personal protection equipment (PPE).

PPE is still in high demand and providing its citizens with these lifesaving tools is the first and most important step the US can take to reduce the size of a second wave. With that in mind, no amount of PPE will stop some resurgence of COVID-19 if the US is opened up. The country will have to shore up its healthcare and infrastructure to deal with a second wave through the purchase of respirators and other important healthcare equipment.”

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Paxlovid enhances treatment options for COVID-19 patients